Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression

[everhopeful]

Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone)...